National Drug Intelligence Center; Agency Information Collection Activities: Proposed Reinstatement With Change of a Previously Approved Collection; Comments Requested, 69144-69145 [E6-20222]
Download as PDF
<![CDATA[
69144
Federal Register / Vol. 71, No. 229 / Wednesday, November 29, 2006 / Notices
jlentini on PROD1PC65 with NOTICES
exhibits an amplification ratio of less than 1
in human cell lines, such as 293 (ECACC No.
85120602), 143B (ECACC No. 91112502),
HeLa (ATCC No. CCL–2) and HaCat
(Boukamp et al. 1988, J Cell Biol 106(3): 761–
71) under the conditions outlined in Example
1 of the present specification’’? ’752 patent,
col. 2, lines 53–59.
(2) Would a virus be considered to
replicate if it sometimes replicated and other
times did not? Is a person of ordinary skill
in the art only concerned with mean values
to the exclusion of standard error analysis?
Would a person of ordinary skill in the art
find viral replication if the mean value were
above 1 even if the confidence intervals
straddled 1? Would a person of ordinary skill
in the art find no replication if the mean
value were below 1 and the confidence
intervals straddled 1?
(3) Is there evidence that MVA–575
possesses a replication ratio of 1 or greater in
HaCaT and other human cells? Is there clear
and convincing evidence that MVA–575
possesses a replication ratio less than 1 in
HaCaT and other human cells?
(4) Given the claim construction in Order
No. 31 regarding ‘‘replication,’’ would it
matter to enablement, written description,
infringement, or domestic industry of the
’752 patent whether MVA–BN replicated less
than MVA–575 if MVA–575 still possessed a
replication ratio less than 1 in human cells?
Is the ALJ’s claim construction of this term
correct to a person of ordinary skill in the
art? Answers to the above should give precise
citations to the record and should take into
account the confidence interval.
(5) Figure 1A indicates that the replication
rates for certain MVA viruses are different.
This is especially apparent at higher
replication rates. Does the difference in
replication rates indicate that these viruses
are not identical? Would the lack of identity
be reflected in the genome? If so, what part
of the genome would reflect the lack of
identity? The coding region? The noncoding
region? Both?
In connection with the final
disposition of this investigation, the
Commission may issue (1) An order that
could result in the exclusion of the
subject articles from entry into the
United States, and/or (2) cease and
desist orders that could result in
respondents being required to cease and
desist from engaging in unfair acts in
the importation and sale of such
articles. Accordingly, the Commission is
interested in receiving written
submissions that address the form of
remedy, if any, that should be ordered.
If a party seeks exclusion of an article
from entry into the United States for
purposes other than entry for
consumption, the party should so
indicate and provide information
establishing that activities involving
other types of entry either are adversely
affecting it or are likely to do so. For
background information, see the
Commission Opinion, In the Matter of
Certain Devices for Connecting
VerDate Aug<31>2005
15:37 Nov 28, 2006
Jkt 211001
Computers via Telephone Lines, Inv.
No. 337–TA–360.
If the Commission contemplates some
form of remedy, it must consider the
effects of that remedy upon the public
interest. The factors the Commission
will consider include the effect that an
exclusion order and/or cease and desist
orders would have on (1) The public
health and welfare, (2) competitive
conditions in the U.S. economy, (3) U.S.
production of articles that are like or
directly competitive with those that are
subject to investigation, and (4) U.S.
consumers. The Commission is
therefore interested in receiving written
submissions that address the
aforementioned public interest factors
in the context of this investigation.
If the Commission orders some form
of remedy, the President has 60 days to
approve or disapprove the
Commission’s action. During this
period, the subject articles would be
entitled to enter the United States under
a bond, in an amount to be determined
by the Commission and prescribed by
the Secretary of the Treasury. The
Commission is therefore interested in
receiving submissions concerning the
amount of the bond that should be
imposed.
Written Submissions: The parties to
the investigation are requested to file
written submissions on the issues under
review. The submissions should be
concise and thoroughly referenced to
the record in this investigation,
including references to exhibits and
testimony. Additionally, the parties to
the investigation, interested government
agencies, and any other interested
persons are encouraged to file written
submissions on the issues of remedy,
the public interest, and bonding. Such
submissions should address the ALJ’s
September 6, 2006, recommended
determination on remedy and bonding.
Complainant and the Commission
investigative attorney are also requested
to submit proposed remedial orders for
the Commission’s consideration.
Complainant is requested to supply the
expiration dates of the patents at issue
and the HTSUS numbers under which
the accused products are imported. The
written submissions and proposed
remedial orders must be filed no later
than the close of business on December
12, 2006. Reply submissions must be
filed no later than the close of business
on December 22, 2006. No further
submissions will be permitted unless
otherwise ordered by the Commission.
Persons filing written submissions
must file with the Office of the Secretary
the original and 12 true copies thereof
on or before the deadlines stated above.
Any person desiring to submit a
PO 00000
Frm 00048
Fmt 4703
Sfmt 4703
document (or portion thereof) to the
Commission in confidence must request
confidential treatment unless the
information has already been granted
such treatment during the proceedings.
All such requests should be directed to
the Secretary of the Commission and
must include a full statement of the
reasons why the Commission should
grant such treatment. See 19 CFR 201.6.
Documents for which confidential
treatment is granted by the Commission
will be treated accordingly. All
nonconfidential written submissions
will be available for public inspection at
the Office of the Secretary.
This action is taken under the
authority of section 337 of the Tariff Act
of 1930, as amended (19 U.S.C. 1337),
and under sections 210.42–.46, .51(a) of
the Commission’s Rules of Practice and
Procedure (19 CFR 210.42–.46, .51(a)).
By order of the Commission.
Issued: November 22, 2006.
Marilyn R. Abbott,
Secretary to the Commission.
[FR Doc. E6–20178 Filed 11–28–06; 8:45 am]
BILLING CODE 7020–02–P
DEPARTMENT OF JUSTICE
[OMB Number 1105–0071]
National Drug Intelligence Center;
Agency Information Collection
Activities: Proposed Reinstatement
With Change of a Previously Approved
Collection; Comments Requested
30-Day Notice of Information
Collection Under Review: Reinstatement
with Change of a Previously Approved
Collection National Drug Threat Survey.
ACTION:
The United States Department of
Justice (DOJ), National Drug Intelligence
Center (NDIC), has submitted the
following information collection request
to the Office of Management and Budget
(OMB) for review and approval in
accordance with the Paperwork
Reduction Act of 1995. The proposed
information collection is published to
obtain comments from the public and
affected agencies. This proposed
information collection was previously
published in the Federal Register
Volume 71, Number 187, page 56552 on
September 27, 2006, allowing for a 60
day comment period.
The purpose of this notice is to allow
for an additional 30 days for public
comment until December 29, 2006. This
process is conducted in accordance with
5 CFR 1320.10.
Written comments and/or suggestions
regarding the items contained in this
notice, especially the estimated public
E:\FR\FM\29NON1.SGM
29NON1
Federal Register / Vol. 71, No. 229 / Wednesday, November 29, 2006 / Notices
burden and associated response time,
should be directed to the Office of
Management and Budget, Office of
Information and Regulatory Affairs,
Attention Department of Justice Desk
Officer, Washington, DC 20503.
Additionally, comments may be
submitted to OMB via facsimile to (202)
395–5806. Written comments and
suggestions from the public and affected
agencies concerning the proposed
collection of information are
encouraged. Your comments should
address one or more of the following
four points:
—Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
—Evaluate the accuracy of the agencies
estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
—Enhance the quality, utility, and
clarity of the information to be
collected; and
—Minimize the burden of the collection
of information on those who are to
respond, including through the use of
appropriate automated, electronic,
mechanical, or other technological
collection techniques or other forms
of information technology, e.g.,
permitting electronic submission of
responses.
jlentini on PROD1PC65 with NOTICES
Overview of this Information Collection
(1) Type of Information Collection:
Extension Reinstatement with Change of
a Previously Approved Collection.
(2) Title of the Form/Collection:
National Drug Threat Survey.
(3) Agency form number, if any, and
the applicable component of the
Department of Justice sponsoring the
collection: Form Number: NDIC Form #
A–34g.
(4) Affected public who will be asked
or required to respond, as well as a brief
abstract: Primary: Federal, State, and
Local, law enforcement agencies. This
survey is a critical component of the
National Drug Threat Assessment and
other reports and assessments produced
by the National Drug Intelligence
Center. It provides direct access to
detailed drug threat data from State and
local law enforcement agencies.
(5) An estimate of the total number of
respondents and the amount of time
estimated for an average respondent to
respond: It is estimated that
approximately 3,500 respondents will
complete a survey response within
approximately 20 minutes.
VerDate Aug<31>2005
15:37 Nov 28, 2006
Jkt 211001
(6) An estimate of the total public
burden (in hours) associated with the
collection: There are an estimated 1,167
total annual burden hours associated
with this collection.
If additional information is required
contact: Ms. Lynn Bryant, Department
Clearance Officer, United States
Department of Justice, Justice
Management Division, Policy and
Planning Staff, Patrick Henry Building,
Suite 1600, 601 D Street, NW.,
Washington, DC 20530.
Dated: November 22, 2006.
Lynn Bryant,
Department Clearance Officer, Department of
Justice.
[FR Doc. E6–20222 Filed 11–28–06; 8:45 am]
BILLING CODE 4410–DC–P
DEPARTMENT OF JUSTICE
[OMB Number 1122–0006]
Office on Violence Against Women;
Agency Information Collection
Activities: Revision of a Currently
Approved Collection; Comments
Requested
30-Day Notice of Information
Collection Under Review: Semi-Annual
Progress Report for the Grants to
Encourage Arrest Policies and
Enforcement of Protection Orders
Program.
ACTION:
The Department of Justice, Office on
Violence Against Women (OVW) has
submitted the following information
collection request to the Office of
Management and Budget (OMB) for
review and approval in accordance with
the Paperwork Reduction Act of 1995.
The proposed information collection is
published to obtain comments from the
public and affected agencies. This
proposed information collection was
previously published in the Federal
Register Volume 71, Number 185, pages
55805–55806 on September 25, 2006,
allowing for a 60-day comment period.
The purpose of this notice is to allow
for an additional 30 days for public
comment until December 29, 2006. This
process is conducted in accordance with
5 CFR 1320.10.
Written comments and/or suggestions
regarding the items contained in this
notice, especially the estimated public
burden and associated response time,
should be directed to The Office of
Management and Budget, Office of
Information and Regulatory Affairs,
Attention Department of Justice Desk
Officer, Washington, DC 20503.
Additionally, comments may be
submitted to OMB via facsimile to (202)
395–5806.
PO 00000
Frm 00049
Fmt 4703
Sfmt 4703
69145
Written comments and suggestions
from the public and affected agencies
concerning the proposed collection of
information are encouraged. Your
comments should address one or more
of the following four points:
(1) Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
(2) Evaluate the accuracy of the
agency’s estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
(3) Enhance the quality, utility, and
clarity of the information to be
collected; and
(4) Minimize the burden of the
collection of information on those who
are to respond, including through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submission of
responses.
Overview of This Information
Collection
(1) Type of Information Collection:
Revision of a currently approved
collection.
(2) Title of the Form/Collection: SemiAnnual Progress Report for Grants to
Encourage Arrest Policies and
Enforcement of Protection Orders
Program.
(3) Agency form number, if any, and
the applicable component of the
Department of Justice sponsoring the
collection: Form Number: 1122–0006.
U.S. Department of Justice, Office on
Violence Against Women.
(4) Affected public who will be asked
or required to respond, as well as a brief
abstract: The affected public includes
the approximately 200 grantees of the
Grants to Encourage Arrest Policies and
Enforcement of Protection Orders
Program (Arrest Program) whose
eligibility is determined by statute. The
Arrest Program was authorized through
the Violence Against Women Act
(VAWA) and reauthorized and amended
by the Violence Against Women Act of
2000 (VAWA 2000) and by the Violence
Against Women Act of 2005 (VAWA
2005). The Arrest Program promotes
mandatory or pro-arrest policies and
encourages jurisdictions to treat
domestic violence and sexual assault as
a serious crime, establish coordinated
community responses and facilitate the
enforcement of protection orders. By
statute, eligible grantees for the Arrest
Program are States, Indian tribal
E:\FR\FM\29NON1.SGM
29NON1
]]>Agencies
[Federal Register Volume 71, Number 229 (Wednesday, November 29, 2006)]
[Notices]
[Pages 69144-69145]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E6-20222]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
[OMB Number 1105-0071]
National Drug Intelligence Center; Agency Information Collection
Activities: Proposed Reinstatement With Change of a Previously Approved
Collection; Comments Requested
ACTION: 30-Day Notice of Information Collection Under Review:
Reinstatement with Change of a Previously Approved Collection National
Drug Threat Survey.
-----------------------------------------------------------------------
The United States Department of Justice (DOJ), National Drug
Intelligence Center (NDIC), has submitted the following information
collection request to the Office of Management and Budget (OMB) for
review and approval in accordance with the Paperwork Reduction Act of
1995. The proposed information collection is published to obtain
comments from the public and affected agencies. This proposed
information collection was previously published in the Federal Register
Volume 71, Number 187, page 56552 on September 27, 2006, allowing for a
60 day comment period.
The purpose of this notice is to allow for an additional 30 days
for public comment until December 29, 2006. This process is conducted
in accordance with 5 CFR 1320.10.
Written comments and/or suggestions regarding the items contained
in this notice, especially the estimated public
[[Page 69145]]
burden and associated response time, should be directed to the Office
of Management and Budget, Office of Information and Regulatory Affairs,
Attention Department of Justice Desk Officer, Washington, DC 20503.
Additionally, comments may be submitted to OMB via facsimile to (202)
395-5806. Written comments and suggestions from the public and affected
agencies concerning the proposed collection of information are
encouraged. Your comments should address one or more of the following
four points:
--Evaluate whether the proposed collection of information is necessary
for the proper performance of the functions of the agency, including
whether the information will have practical utility;
--Evaluate the accuracy of the agencies estimate of the burden of the
proposed collection of information, including the validity of the
methodology and assumptions used;
--Enhance the quality, utility, and clarity of the information to be
collected; and
--Minimize the burden of the collection of information on those who are
to respond, including through the use of appropriate automated,
electronic, mechanical, or other technological collection techniques or
other forms of information technology, e.g., permitting electronic
submission of responses.
Overview of this Information Collection
(1) Type of Information Collection: Extension Reinstatement with
Change of a Previously Approved Collection.
(2) Title of the Form/Collection: National Drug Threat Survey.
(3) Agency form number, if any, and the applicable component of the
Department of Justice sponsoring the collection: Form Number: NDIC Form
A-34g.
(4) Affected public who will be asked or required to respond, as
well as a brief abstract: Primary: Federal, State, and Local, law
enforcement agencies. This survey is a critical component of the
National Drug Threat Assessment and other reports and assessments
produced by the National Drug Intelligence Center. It provides direct
access to detailed drug threat data from State and local law
enforcement agencies.
(5) An estimate of the total number of respondents and the amount
of time estimated for an average respondent to respond: It is estimated
that approximately 3,500 respondents will complete a survey response
within approximately 20 minutes.
(6) An estimate of the total public burden (in hours) associated
with the collection: There are an estimated 1,167 total annual burden
hours associated with this collection.
If additional information is required contact: Ms. Lynn Bryant,
Department Clearance Officer, United States Department of Justice,
Justice Management Division, Policy and Planning Staff, Patrick Henry
Building, Suite 1600, 601 D Street, NW., Washington, DC 20530.
Dated: November 22, 2006.
Lynn Bryant,
Department Clearance Officer, Department of Justice.
[FR Doc. E6-20222 Filed 11-28-06; 8:45 am]
BILLING CODE 4410-DC-P
